Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in Wisconsin
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Wisconsin
| Provider | Medicare | Services |
|---|---|---|
| Nvira Genetics Llc | $40.55 | 4.4K |
| Covid Care Zone Inc | $40.55 | 427 |
Wisconsin Pricing in Context
In Wisconsin, CPT code 87811 (Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)) carries an average Medicare payment of $40.53 — 1% above the national benchmark of $40.14. 105 providers across the state submitted claims for this procedure in 2023, performing 5.8K total services. Individual payments in WI ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Wisconsin is $120.57, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Wisconsin sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Wisconsin lands near $85.91, with self-pay cash prices typically around $63.55. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cost in Wisconsin?
The average Medicare payment for Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in Wisconsin is $40.53, which is 1% above the national average of $40.14. Providers in WI typically bill $120.57 for this procedure.
What does Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cost with insurance in Wisconsin?
With commercial insurance in Wisconsin, Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) costs an estimated $85.91. Without insurance, the estimated cash price is $63.55. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in Wisconsin?
105 providers in Wisconsin billed Medicare for Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in 2023, performing 5.8K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cheaper in Wisconsin than the national average?
No — Detection Test By Immunoassay With Direct Visual Observation For Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) costs 1% above the national average in Wisconsin. The state average Medicare payment is $40.53 compared to $40.14 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.